Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 19;8(2):190. doi: 10.3390/vaccines8020190

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Comparison of antibody response against the mumps virus and nucleocapsid proteins (NPs). The serology of P. vivax-infected individuals (n = 40), non-infected individuals (n = 40), and individuals who were immunized or had mumps from a non-endemic P. vivax area (n = 12) was investigated using a commercial ELISA kit. The dashed line in the chart indicates the minimum threshold (OD = 0.3) for considering an individual to be immunized against the mumps virus, as indicated in the supplier’s manual. The results were statistically compared using one-way ANOVA followed by Tukey’s test. Significant differences between groups are denoted on the graph: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Non-significant (ns) differences are indicated (p > 0.05).